Vertex Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,465
1,398
1,127
1,497
2,090
3,168
Total Accounts Receivable
86
90
189
204
347
415
Inventories
14
31
57
78
112
124
Other Current Assets
24
28
35
53
100
136
Total Current Assets
1,589
1,547
1,407
1,832
2,649
3,843
Net Property, Plant & Equipment
697
716
698
698
789
812
Total Investments and Advances
-
-
22
20
20
-
Long-Term Note Receivable
-
-
30
-
-
-
Intangible Assets
31
69
335
335
79
50
Other Assets
2
3
7
12
8
41
Total Assets
2,319
2,335
2,499
2,897
3,546
6,246
ST Debt & Current Portion LT Debt
17
32
87
319
23
Accounts Payable
49
71
75
61
74
Other Current Liabilities
332
265
344
412
711
Total Current Liabilities
398
368
506
793
807
Long-Term Debt
490
793
739
521
584
Provision for Risks & Charges
14
13
7
2
-
Deferred Taxes
-
15
110
134
6
Other Liabilities
61
50
41
109
106
Total Liabilities
963
1,238
1,405
1,559
1,504
Common Equity (Total)
1,356
1,075
940
1,157
2,029
Total Shareholders' Equity
1,356
1,075
940
1,157
2,029
Total Equity
1,356
1,096
1,094
1,338
2,042
Liabilities & Shareholders' Equity
2,319
2,335
2,499
2,897
3,546
Accumulated Minority Interest
-
21
154
182
14
About Vertex Pharmaceuticals
View Profile
